Exchange: NASDAQ·Updated 01:42 AM EDT
LEGN logo

LEGNLegend Biotech

$23.95
$0.41
(1.74%)
Overnight
Prev Close $23.54
EarningsAug 10
Mkt Cap$4.37B
Vol2.07M
News
all
press releases
Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress
Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress...
Yahoo! Finance: News
More News
Why Is Legend Biotech Stock Falling Thursday?
Legend Biotech (LEGN) shares drop in premarket trading after pricing a $226M public offering. Get the latest technical levels here.read more...
Benzinga
Legend Biotech, Sleep Number And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
US stock futures up, Nasdaq futures 1% higher. Legend Biotech (LEGN) priced 7.7 million ADSs at $29.35 each, shares down 9% in pre-market trading.read more...
Benzinga
These Analysts Revise Their Forecasts On Legend Biotech After Q1 Results
Legend Biotech (LEGN) reported Q1 losses of 3 cents per share and sales of $305.1 million, missing estimates. Stock rose 1.3% to $28.63. Analysts maintained ratings and adjusted price targets.read...
Benzinga
Legend Biotech Q1 Earnings Call Highlights
Legend Biotech Q1 Earnings Call Highlights...
Yahoo! Finance: News
Legend Biotech (LEGN) Projected to Post Earnings on Tuesday
Legend Biotech (NASDAQ:LEGN) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...
MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Decreases Stake in Legend Biotech Corporation Sponsored ADR $LEGN
Zurcher Kantonalbank Zurich Cantonalbank lowered its stake in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 89.4% in the fourth quarter, according to the company in its most...
MarketBeat
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen research firms that are currently covering the...
MarketBeat
Legend Biotech Corporation Sponsored ADR $LEGN Stock Holdings Lowered by Matthews International Capital Management LLC
Matthews International Capital Management LLC reduced its holdings in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 7.0% during the 4th quarter, according to its most recent...
MarketBeat
Legend Biotech (LEGN) Moves 18.4% Higher: Will This Strength Last?
Legend Biotech (LEGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
<
1
2
...
>

Advertisement|Remove ads.